Sikandar Khan1, Amira Amjad1, David Rowland2. 1. Department of Professional Psychology, Bahria University, Islamabad, Pakistan. 2. Department of Psychology, Valparaiso University, Valparaiso, IN, USA. Electronic address: david.rowland@valpo.edu.
Abstract
INTRODUCTION: Psychosexual counseling may enhance sexual performance outcomes in men with erectile dysfunction (ED) treated with a phosphodiesterase type 5 (PDE5) inhibitor. AIM: To determine the potential long-term effects of cognitive behavioral therapy (CBT) on Pakistani men with ED who had undergone treatment with a PDE5 inhibitor (PDE5i). METHODS: In a 15-18-month follow-up, we reassessed a subsample of 20 men who had been treated with either PDE5is (monotherapy group) or CBT + PDE5i (combined group) on 2 dimensions: sexual functioning and mental health functioning. MAIN OUTCOME MEASURE: International Index of Erectile Function was used to assess sexual function, and 2 Mental Health Inventory subscales were used to assess anxiety and depression. A brief semi-structured interview assessed men's current sexual status and evaluation of their CBT experience. RESULTS: Men in the combined group continued to show improvement on erectile function and several other sexual parameters, whereas men in the monotherapy group showed either no further improvement or a decrement in sexual response parameters. The results did not appear to be related to changes in relationship satisfaction or mental health indices. CLINICAL IMPLICATIONS: Adjunctive CBT shows long-term benefits in men with ED treated with a PDE5i. STRENGTH & LIMITATIONS: Effect sizes were strong, overcoming the small sample size, but attrition may affect the generalizability of the findings. CONCLUSION: In the first long-term follow-up study of its kind, CBT proved an effective and supportive adjunctive treatment for Pakistani men with ED taking a PDE5i, with benefits extending long after the end of treatment. Khan S, Amjad A, Rowland D. Potential for Long-Term Benefit of Cognitive Behavioral Therapy as an Adjunct Treatment for Men with Erectile Dysfunction. J Sex Med 2019;16:300-306.
INTRODUCTION: Psychosexual counseling may enhance sexual performance outcomes in men with erectile dysfunction (ED) treated with a phosphodiesterase type 5 (PDE5) inhibitor. AIM: To determine the potential long-term effects of cognitive behavioral therapy (CBT) on Pakistani men with ED who had undergone treatment with a PDE5 inhibitor (PDE5i). METHODS: In a 15-18-month follow-up, we reassessed a subsample of 20 men who had been treated with either PDE5is (monotherapy group) or CBT + PDE5i (combined group) on 2 dimensions: sexual functioning and mental health functioning. MAIN OUTCOME MEASURE: International Index of Erectile Function was used to assess sexual function, and 2 Mental Health Inventory subscales were used to assess anxiety and depression. A brief semi-structured interview assessed men's current sexual status and evaluation of their CBT experience. RESULTS:Men in the combined group continued to show improvement on erectile function and several other sexual parameters, whereas men in the monotherapy group showed either no further improvement or a decrement in sexual response parameters. The results did not appear to be related to changes in relationship satisfaction or mental health indices. CLINICAL IMPLICATIONS: Adjunctive CBT shows long-term benefits in men with ED treated with a PDE5i. STRENGTH & LIMITATIONS: Effect sizes were strong, overcoming the small sample size, but attrition may affect the generalizability of the findings. CONCLUSION: In the first long-term follow-up study of its kind, CBT proved an effective and supportive adjunctive treatment for Pakistani men with ED taking a PDE5i, with benefits extending long after the end of treatment. Khan S, Amjad A, Rowland D. Potential for Long-Term Benefit of Cognitive Behavioral Therapy as an Adjunct Treatment for Men with Erectile Dysfunction. J Sex Med 2019;16:300-306.
Authors: Benjamin Evans-Durán; Dean A Tripp; Jeffrey Campbell; R Christopher Doiron; J Curtis Nickel Journal: Can Urol Assoc J Date: 2022-06 Impact factor: 2.052
Authors: Marieke Dewitte; Carlo Bettocchi; Joanna Carvalho; Giovanni Corona; Ida Flink; Erika Limoncin; Patricia Pascoal; Yacov Reisman; Jacques Van Lankveld Journal: Sex Med Date: 2021-10-07 Impact factor: 2.491